Gillette
This article was originally published in The Rose Sheet
Executive Summary
Global launch of prescription drug hair removal cream Vaniqa (eflornithine 15%) to be handled by Chicago-based DDB Corbett, a joint venture between Frank J. Corbett, Inc. and DDB Chicago. The firm will handle all professional communications, direct-to-consumer advertising and Web site development of the drug product. The Vaniqa launch will begin in the U.S. and roll out to four additional countries. Gillette and Bristol-Myers Squibb filed the Vaniqa NDA Sept. 27 (1"The Rose Sheet" Oct. 11, 1999, p. 12). Under the agreement, BMS is handling the FDA submissions and clinical development and will market the prescription product in partnership with Gillette